Anti-PD-1 blockade

immune checkpoint inhibitor targeting PD-1

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-PD-1 blockade, covering 2023-09-22 to 2023-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant [Phase 2]